Results 311 to 320 of about 387,405 (380)

Secondary analysis of a combined harm‐reduction treatment and extended‐release naltrexone randomized clinical trial for alcohol use disorder: Differences across race, ethnicity and sex assigned at birth

open access: yesAddiction, EarlyView.
Abstract Background and Aims In a prior randomized clinical trial (RCT), combined pharmacobehavioral harm‐reduction treatment improved alcohol outcomes and physical health‐related quality of life (PH‐QoL). In this secondary analysis, we tested race, ethnicity and sex assigned at birth as predictors and moderators of these effects.
Silvi C. Goldstein   +4 more
wiley   +1 more source

CYP2C19 Loss-of-Function Is an Independent Risk Factor of Coronary Artery Disease in Patients With Hypertension. [PDF]

open access: yesJ Clin Lab Anal
Wei G   +10 more
europepmc   +1 more source

Intranasal cocaine self-administration in male mice. [PDF]

open access: yesNat Commun
Erickson KR   +9 more
europepmc   +1 more source

Latent profile analysis of trait impulsivity facets and associations with resilience, problematic alcohol use, and quality of life. [PDF]

open access: yesAlcohol Clin Exp Res (Hoboken)
Meyer HH   +6 more
europepmc   +1 more source

The CAGE questionnaire: validation of a new alcoholism screening instrument.

American Journal of Psychiatry, 1974
The CAGE questionnaire, a new brief alcoholism screening test, was administered to all patients (N = 366; 39 percent alcoholic) admitted to a psychiatric service over a one-year period.
D. Mayfield   +2 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy